In B16.OVA tumors, ∼14% of the CD4+ T cell population was Foxp3GFP+, as opposed to the ∼10% observed in the tumor-draining and non-draining LN (Figure 1A and 1B), and their frequency increased during tumor growth (Figure 1C). This evidence concerns the gene CD4 and neoplasm.